Product NDC: | 0179-0096 |
Proprietary Name: | RESCRIPTOR |
Non Proprietary Name: | delavirdine mesylate |
Active Ingredient(s): | 200 mg/1 & nbsp; delavirdine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0096 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020705 |
Marketing Category: | NDA |
Start Marketing Date: | 20110706 |
Package NDC: | 0179-0096-70 |
Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0096-70) |
NDC Code | 0179-0096-70 |
Proprietary Name | RESCRIPTOR |
Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0096-70) |
Product NDC | 0179-0096 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | delavirdine mesylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110706 |
Marketing Category Name | NDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | DELAVIRDINE MESYLATE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |